The proposed sale is small in size and follows a same-day option exercise, typical of routine insider transactions. Monitor for any subsequent Form 4 filings to confirm execution, but no immediate catalyst is indicated.
Price Chart
Executive Summary
James R. Kasinger, an officer of CRISPR Therapeutics AG, filed a Form 144 on October 6, 2026, indicating intent to sell 1,990 shares of common stock with an approximate market value of $119,481.19. The shares were acquired via stock option exercise on the same date. This is a relatively small sale relative to the company's market cap and does not signal a material change in insider sentiment.
Key Facts
- Filer: James R. Kasinger, an officer of CRISPR Therapeutics AG
- Proposed sale: 1,990 shares of common stock
- Estimated value: $119,481.19
- Shares acquired via stock option exercise on October 6, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Filing date: October 6, 2026
Financial Impact
Proposed sale of 1,990 shares valued at approximately $119,481.19, representing a small fraction of the company's market capitalization.
Risk Factors
- Insider selling, even small, can be perceived negatively by the market
- Additional unannounced sales by the officer could follow
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010087 |
| Document: 0001950047-26-010087-index.html | 0001950047-26-010087 |
| Document: 0001950047-26-010087.txt | 0001950047-26-010087 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Insider Cluster | $50.50 | awaiting T+20 | — | $49.42 (+2.14%) |
Oct 19, 2026 7d ago | 8-K | $49.88 | awaiting T+20 | — | $49.42 (−0.92%) |
Oct 16, 2026 10d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.42 (−1.24%) |
Oct 16, 2026 10d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.42 (+1.24%) |
Oct 15, 2026 11d ago | Insider Cluster | $49.25 | awaiting T+20 | — | $49.42 (+0.35%) |
Oct 14, 2026 12d ago | 144 | $51.52 | awaiting T+20 | — | $49.42 (−4.08%) |
Oct 6, 2026 20d ago | 144 | $52.35 | awaiting T+20 | — | $49.42 (−5.60%) |
Sep 24, 2026 4w ago | Insider Cluster | $54.23 $49.39 | ▲ +8.92% | ▲ +7.45% | $49.42 (+8.87%) |
Aug 28, 2026 8w ago | Press Release | $57.72 $54.23 | ▼ −6.05% | ▼ −6.56% | $49.42 (−14.38%) |
Aug 3, 2026 12w ago | Press Release | $53.07 $56.82 | ▲ +7.07% | ▲ +8.30% | $49.42 (−6.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers